Bonterra Announces Closing of Brokered Private Placement for Proceeds of $8.5 Million

In This Article:

Val-d'Or, Quebec--(Newsfile Corp. - May 3, 2024) - Bonterra Resources Inc. (TSXV: BTR) (OTCQX: BONXF) (FSE: 9BR2) ("Bonterra" or the "Company") is pleased to announce the closing of its previously announced "best efforts" private placement (the "Offering") for gross proceeds of $8,541,250, which includes the full exercise of the over-allotment option for gross proceeds of $767,500. Under the Offering, the Company sold (i) 5,250,000 flow-through units of the Company to purchasers (each, a "FT Unit") at a price of $0.445 per FT Unit for gross proceeds of $2,336,250 from the sale of FT Units; and (ii) 24,820,000 units of the Company (each, a "Unit", and together with the FT Units, the "Offered Units") at a price of $0.25 per Unit for gross proceeds of $6,205,000 from the sale of Units.

Under the Offering, Eight Capital acted as lead agent and sole bookrunner on behalf of a syndicate of agents that included Cormark Securities Inc. (collectively, the "Agents").

Each FT Unit consists of one common share of the Company (each, a "FT Share") and one common share purchase warrant (each, a "Warrant"). The FT Shares and Warrants comprising the FT Units will qualify as "flow-through shares" within the meaning of the Income Tax Act (Canada) and the Taxation Act (Quebec). Each Unit consists of one common share of the Company (each, a "Unit Share") and one Warrant. Each Warrant (including a Warrant comprising the FT Units) entitles the holder to purchase one common share of the Company (each, a "Warrant Share") at a price of C$0.31 at any time on or before May 3, 2028.

20,000,000 Units (the "LIFE Units") were sold pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 - Prospectus Exemptions ("NI 45-106"). The LIFE Units are immediately freely tradeable under applicable Canadian securities legislation for Canadian purchasers. The remaining 4,820,000 Units, as well as the 5,250,000 FT Units, were distributed by way of the "accredited investor", "minimum amount investment" and other exemptions under NI 45-106 in certain provinces of Canada, and are subject to a four-month restricted period in Canada ending on September 3, 2024. The Offering is subject to certain conditions including, but not limited to, the receipt of all required regulatory approvals including final approval of the TSX Venture Exchange.

The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes.